Families Share Pleasure and Pain at The March

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 11
Volume 7
Issue 11

WASHINGTON--It wasn’t all rhetoric and oration at The March. It was also a time for reflection on loved ones lost and hope for the future; a time to celebrate survivorship and bond in a way only survivors understand; a time to learn more about cancer

WASHINGTON--It wasn’t all rhetoric and oration at The March. It was also a time for reflection on loved ones lost and hope for the future; a time to celebrate survivorship and bond in a way only survivors understand; a time to learn more about cancer.

In a three-block-long part of the National Mall, people wandered from booth to booth and event to event; children played; celebrities such as model Cindy Crawford and football great Roosevelt (Rosey) Grier mingled with the crowd; dancers, singers, and musicians performed; and people remembered.

The Children’s Cancer Awareness Project unveiled its Children’s Cancer Quilt, more than 40 panels made up of individual 8.5-in × 8.5-in squares. The idea originated with Tracey Clark of Columbia, Md, and Kathy Cales of Manning, SC--both mothers of a child with cancer--to call attention to childhood cancers. Each quilt square, assembled by a parent, sibling, relative, or friend, stands "for a child who has been diagnosed with cancer and his or her fight to stay alive," the project organizers said.

At the Wall of Courage, people displayed mementos for those living and dead whose lives have been touched by cancer. Drawings, poems, and artificial and real flowers were hung in one of the most popular attractions at The March.

While children attended soccer and basketball clinics, frolicked with clowns, and negotiated an obstacle course, adults attended 2-hour-plus sessions of a public forum sponsored by the American Association for Cancer Research (AACR) where experts--including Martin D. Abeloff, MD, director of the Johns Hopkins Oncology Center, and NCI director Richard D. Klausner, MD--discussed recent cancer advances and fielded questions from the audience.

At some 100 booths along the Mall, people obtained information on specific cancers and nutrition from advocacy and support groups; learned about advances in chemotherapy from pharmaceutical firms; and heard about complementary wellness therapies, including yoga and massage therapy.

Even during the rally, people roamed the booths and displays, listening to speakers over powerful amplifiers and watching them on giant TV screens.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content